MoneyWorks4Me

Biogen Pharmachem - Quaterly Results

03 Aug 2022 Evaluate
The Sales for the quarter ended June 2022 of Rs. -15.37 million declined by -222.76% from Rs. 12.52 millions.The Net Loss for the quarter ended June 2022 is Rs. -15.90 millions as compared to Net Profit of Rs. 2.02 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -15.90% as compared to 2.02% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales -15.37 12.52 -222.76 -15.37 12.52 -222.76 21.62 0.15 14313.33
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.00 0.00
PBIDT -15.90 2.02 -887.13 -15.90 2.02 -887.13 -0.08 -16.03 -99.50
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -15.90 2.02 -887.13 -15.90 2.02 -887.13 -0.08 -16.03 -99.50
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -15.90 2.02 -887.13 -15.90 2.02 -887.13 -0.08 -16.03 -99.50
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -15.90 2.02 -887.13 -15.90 2.02 -887.13 -0.08 -16.03 -99.50
Equity 652.60 652.60 0.00 652.60 652.60 0.00 652.60 652.60 0.00
PBIDTM(%) 103.45 16.13 541.17 103.45 16.13 541.17 -0.37 -10686.67 -100.00
Peers
Company Name CMP
Redington 392.20
Amrapali Industries 37.05
Adani Enterprises 3100.00
Rashi Peripheral 805.00
PDS 348.90
View more..